Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
US9879090B2 · kind B2 · utility
3Cited by
1References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 4, 2014 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Jan 24, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to isolated VHHs directed against human Glycophorin A. The present invention also relates to fusion proteins comprising the VHH according to the invention that is fused to at least one heterologous polypeptide and immunoconjugates comprising the VHH according to the invention that is conjugated to at least one chemical compound and their use in therapeutic or diagnostic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.